Ming Xian - Jun 20, 2024 Form 4 Insider Report for MEDIFAST INC (MED)

Role: Director
Signature: /s/ Jason L. Groves, attorney-in-fact
Stock symbol: MED
Transactions as of: Jun 20, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/24/2024, 05:47 PM
Previous filing: Nov 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MED	Restricted Stock Units (cash settled)	Award	$0	+10.1K	+210.87%	$0.00	15K	Jun 20, 2024	Common Stock	10.1K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the contingent right to receive 10,149 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

Content

Represents the contingent right to receive 10,149 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.